How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies

Abstract Programmed death ligand-1 (PD-L1) expression is a key biomarker to screen patients for PD-1/PD-L1-targeted immunotherapy. However, a subjective assessment guide on PD-L1 expression of tumor-infiltrating immune cells (IC) scoring is currently adopted in clinical practice with low concordance...

Full description

Bibliographic Details
Main Authors: Xinran Wang, Liang Wang, Hong Bu, Ningning Zhang, Meng Yue, Zhanli Jia, Lijing Cai, Jiankun He, Yanan Wang, Xin Xu, Shengshui Li, Kaiwen Xiao, Kezhou Yan, Kuan Tian, Xiao Han, Junzhou Huang, Jianhua Yao, Yueping Liu
Format: Article
Language:English
Published: Nature Portfolio 2021-05-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-021-00268-y